Quality Sustainability in Pharma: Where Culture Becomes the True Competitive Edge
Discover how pharma leaders can build quality sustainability through resilient systems, adaptive culture and a culture of continuous improvement.
Discover how pharma leaders can build quality sustainability through resilient systems, adaptive culture and a culture of continuous improvement.

Zydus Lifesciences extends its Sunshine Healthcare Lanka JV investment deadline to December 2026, keeping a 50% equity stake transaction in play.

Godavari Biorefineries secures a Mexican patent for antiviral compounds, extending its IP portfolio into Latin America.

Bayer's $2.2B U.S. site investment brings its five-year domestic pharma spend to $9.2B, with site details still pending.

FDA extends Novo Nordisk's denecimig BLA review citing facility remediation, with no new action date set and a 2027 US launch still targeted.
Latest edition
SPONSORED
SPONSORED
SPONSORED
Oct 20
Oct 28From native content to event partnerships, we help brands earn the attention of a hard-to-reach, senior audience — without breaking the reading experience.
See partnership options →Explore expert-led guides crafted for pharma professionals. Log in to download and stay ahead.








Join thousands of pharma professionals getting our sharpest reporting, briefings and guides — free.
